Pages that link to "Q45077882"

The following pages link to The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea (Q45077882):

Displaying 39 items.

• Emerging blood-based biomarkers for detection of gastric cancer (Q26778026) (← links)
• Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis (Q26778122) (← links)
• Gastric cancer: prevention, screening and early diagnosis (Q26860418) (← links)
• Diagnosis and management of high risk group for gastric cancer (Q28084323) (← links)
• The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research (Q33921574) (← links)
• Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis (Q34069642) (← links)
• Serological assessment of gastric mucosal atrophy in gastric cancer (Q34145097) (← links)
• The role of serum pepsinogen in the detection of gastric cancer (Q34206645) (← links)
• Strategy for Eliminating Gastric Cancer in Japan (Q34300591) (← links)
• Correlations among endoscopic, histologic and serologic diagnoses for the assessment of atrophic gastritis (Q34305478) (← links)
• Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study (Q34632505) (← links)
• Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population (Q35065659) (← links)
• The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China (Q35079534) (← links)
• Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer (Q35261353) (← links)
• Effect of Helicobacter pylori Eradication on the Development of Reflux Esophagitis and Gastroesophageal Reflux Symptoms: A Nationwide Multi-Center Prospective Study (Q35619147) (← links)
• Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible? (Q36117678) (← links)
• Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome (Q36194202) (← links)
• Correlation between Endoscopic and Histological Diagnoses of Gastric Intestinal Metaplasia (Q36609552) (← links)
• Implementation of gastric cancer screening - the global experience (Q38273499) (← links)
• Trastuzumab Inhibits Growth of HER2-Negative Gastric Cancer Cells Through Gastrin-Initialized CCKBR Signaling (Q38853156) (← links)
• Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer. (Q39787119) (← links)
• The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case-control study in Korea (Q40116541) (← links)
• Increase in plasma acyl ghrelin levels is associated with abatement of dyspepsia following Helicobacter pylori eradication (Q40978401) (← links)
• Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection (Q41732158) (← links)
• Low Levels of Pepsinogen I and Pepsinogen I/II Ratio are Valuable Serologic Markers for Predicting Extensive Gastric Corpus Atrophy in Patients Undergoing Endoscopic Mucosectomy (Q42572970) (← links)
• Serum pepsinogen reference intervals in apparently healthy Chinese population with latex enhanced turbidimetric immunoassay (Q43452551) (← links)
• Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years (Q48203004) (← links)
• Glycomic profiling of targeted serum haptoglobin for gastric cancer using nano LC/MS and LC/MS/MS. (Q48251620) (← links)
• Predictive power of serum pepsinogen tests for the development of gastric cancer in comparison to the histologic risk index (Q51777433) (← links)
• Prevalence and clinicopathologic characteristics of gastric cardia cancer in South Korea. (Q53361856) (← links)
• Effect of endoscopic screening at 1-year intervals on the clinicopathologic characteristics and treatment of gastric cancer in South Korea. (Q53395672) (← links)
• The correlation of endoscopic and histological diagnosis of gastric atrophy. (Q53501867) (← links)
• Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea. (Q53647021) (← links)
• Reduced serum vascular endothelial growth factor receptor‐2 (sVEGFR‐2) and sVEGFR‐1 levels in gastric cancer patients (Q54621257) (← links)
• Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels. (Q54858925) (← links)
• Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm (Q58598804) (← links)
• The Value of Pepsinogen in GC Screening: A Systematic Review and Meta-Analysis (Q64230711) (← links)
• Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. (Q64900104) (← links)
• Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea (Q90164570) (← links)